Reporting And Data

Qualified laboratories, offices of providers, and medical facilities shall report any result of a blood test for lead screening obtained by using a capillary specimen and which indicates an amount of lead in the blood that is greater than the amount designated by the Council of State and Territorial Epidemiologists.

Reporting of MIS-C associated with COVID-19 is required under Nevada's communicable disease reporting statutes and regulations as an "extraordinary occurrence of illness". The case definition of MIS-C is: an individual aged <21 years presenting with fever, laboratory evidence of inflammation, and evidence of clinically severe illness requiring hospitalization, with multisystem (>2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological); AND no alternative plausible diagnoses; AND positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms.

Although many of these requirements apply to individual medical professionals and other types of hospitals and health care facilities, the information is presented solely to support Critical Access Hospitals. The reporting requirements and legal mandates on this site are not an exhaustive list and Nevada Rural Hospital Partners, Inc. bears no responsibility or liability for any hospitals' or providers' failure to comply with Federal or State laws or regulations.